Immune Repertoire Sequencing Market to Grow at a CAGR of Over 7% Throughout 2026

Posted by Arslan on March 22nd, 2019

The various trends and patterns prevailing in the concerned market, Market Research Reports Search Engine (MRRSE) has included a new report titled “Immune Repertoire Sequencing Market” to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future.

Past several years have witnessed greater throughput next-generation sequencing evolve as a potent tool to profile T- and B-cell receptor repertoires at the single-cell level. Immune repertoire sequencing has gained traction as it assists in profiling the antigen-specific information and has become imperative to comprehend auto-defense mechanism of the body against any foreign agent.

The augmentation of the immune repertoire sequencing market can be attributed to the rising incidence of cancer and other contagious diseases. Besides, there has been growing genomic based research which is expected to propel the market for immune repertoire sequencing market. These aforementioned insights are according to the report titled, “Global Market Study on Immune Repertoire Sequencing: Research Center End Use Segment to Hold Significant Revenue Share Through 2026 Owing to Increased Focus on Cancer Immunotherapy Research,” which has been lately incorporated in the exhaustive repository of Market Research Reports Search Engine (MRRSE).

Analyzing a host of factors in terms of revenue, the market for immune repertoire sequencing is expected to expand at a CAGR of over 7 % during the forecast period 2018-2026. Countries such as Japan and China have witnessed advancement in genome sequencing and tremendous development in biomedical research which is estimated to propel the growth of the market in the region. On the other hand, owing to considerable price drop in high-throughput sequencing, the immune repertoire sequencing market is projected to gain traction in MEA and Latin America. North America is set to dominate the market on the back of surged scale of sequencing projects and widespread presence of leading companies in high-throughput sequencing. 

The report provides a comprehensive analysis on the immune repertoire sequencing market through quantitative and qualitative analysis. Further, the report delves into drivers, restraints, trends and opportunities which have significant influence in the growth of the market. The report segregates the market to provide an in-depth view of immune repertoire sequencing. The market is segregated with respect to component type, application, end-users and regions.

The report starts with executive summary followed by market opportunity analysis. The report also includes macro-economic factors and product mapping. The final section of the report includes competitive scenario with a dashboard view. This section encompasses company overview, product portfolio, financial overview, recent development and strategy. Prominent companies elucidated in the report are Thermo Fisher Scientific, Illumina, BGI, Takara Bio Inc. and F. Hoffmann-La Roche Ltd, among others.

The research methodology in this report consists of secondary sources, primary sources and analysis from panel of expert. Secondary sources applied in the report include, but are not limited to annual reports, SEC filings, government document, World Bank database, investors’ presentation, market reports, relevant patent, statistical and regulatory database. Primary sources include telephonic interviews, honest reviews and e-mail interactions of the market across regions.  Expert panel relentlessly analyzes the report in order to offer readers with worth wile report. The assessment of the market performance across geography is based upon Y-o-Y growth.